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Abstract 
Sickle haemoglobin (HbS) and glucose–6–phosphate dehydrogenase (G6PD) enzyme deficiency 
genes are known to offer reliable protection against falciparum malaria in malaria endemic areas 
of the world. However, the mechanism of protection is not yet completely understood. In this 
study, we investigated the contribution of HbS and G6PD enzyme deficiency status in 
ameliorating the severity of malaria attack by comparing the clinical symptoms, parasitaemia and 
haematological profiles of Plasmodium falciparum–infected volunteer children. The selected 
group of children, G6PD deficient sickle heterozygotes (HbAS) (n = 5), G6PD non–deficient 
HbAS (n = 30), G6PD deficient dominant homozygotes (HbAA) (n = 10) and G6PD non–
deficient HbAA (n = 30) were monitored for a period of one year with a view to elucidating 
further the involvement of HbS and G6PD enzyme deficiency in the protection of children 
against plasmodial infection. Results revealed greater severity (indicated by malarial anaemia), 
higher incidence of atypical thrombocytopenia, high white blood cell (WBC) counts and 
significantly higher (P < 0.05) parasite density and percentage parasitaemia in G6PD non–
deficient HbAA subjects compared to G6PD non–deficient HbAS, G6PD deficient HbAS subject 
and G6PD deficient HbAA. Less severe clinical malarial symptoms were also observed more in 
G6PD deficient HbAS when compared to G6PD non-deficient HbAA subjects during malaria 
attack. These results seem to indicate that inheriting both genetic defects reduces the profligacy 
of malaria parasite and hence, ameliorate the severity of acute falciparum malaria. Consequently, 
selective advantage against fatal falciparum malaria seems to be conferred since malarial 
anaemia, parasitaemia and severe malarial symptoms were significantly reduced. 
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Plasmodium falciparum, a mosquito–borne 
haematoprotozoan parasite, is the main cause of 
disease and death in African countries1,2. As a 
result of heterozygous and hemizygous 
advantage against malaria, the inherited 
haemoglobinopathies and red cell 
enzymopathies are the commonest monogenic 
diseases in the world3. Both sickle cell trait and 
G6PD deficiency co-exists in almost 11% 
American black population4, as well as in 
Cameroonian populations5. 
 
Glucose-6-phosphate dehydrogenase (G6PD) 
one of the most common X-linked recessive 
hereditary enzymopathy affecting erythrocyte 
metabolism6 catalyses the first step of the 
pentose phosphate pathway (PPP), leading to the 
production of reduced nicotinamide adenine 
dinucleotide phosphate (NADPH) within the 
erythrocytes and playing a critical role in the 
metabolism of glucose and in maintaining the 
balance of reduced/oxidized state of glutathione, 
an antioxidant in cells. Reduced glutathione 
(GSH) helps to maintain a reduced environment 
within the red cell and enhances the ability of 
the cell to withstand haemolysis that could result 
from oxidative damage following exposure to 
oxidant drugs such as primaquine7,8,9. Increased 
oxidative stress in G6PD deficient cells and 
haemolytic episodes related to altered PPP and 
glutathione metabolism is well documented7. 
Plasmodium infected G6PD deficient cells are 
thought to impair parasite growth, as they serve 
as an unstable host for the parasite or behave as 
a suicidal package being rapidly sequestered in 
the spleen once it is infected10. 
 
Sickle haemoglobin (HbS) gene is associated 
with a point mutation at the sixth codon of the β-
globin gene resulting in the synthesis of mutant 
HbS (β6 Glu→Val). Although HbS homozygousity 
is associated with sickle cell anaemia (SCA), 
individuals heterozygous for HbS variant, are 
said to be protected against severe malaria11. 
Haematological crisis in SCA are manifested by 
a sudden exacerbation of anaemia with a drop in 
haemoglobin concentration, probably due to 
polymerisation and destruction of HbS and acute 
splenic sequestration of deoxygenated sickled 
red blood cells. Aplastic crisis may also result in 
an attempt to compensate for destruction.  
 
The host’s clinical presentation, progress to 
disease and sometimes death from malaria 
infection is influenced by the host’s age, 
immunity to malaria, genotype and pregnancy, 
and by the species, virulence, strain and perhaps 
the geographic origin of the parasite12. Anaemia 
in P. falciparum malaria could be caused by 
such factors as bone marrow suppression, red 
blood cells haemolysis and ineffective 
erythropoiesis. Anaemia occurs when the 
concentration of haemoglobin falls below what 
is normal for a person’s age, gender and 
environment, resulting in the reduction of the 
oxygen carrying capacity of the blood8. Severe 
anaemia occurs 1.42 – 5.66 million times 
annually and kills 190,000 – 974,000 children 
less than five (5) years old annually13. Malarial 
anaemia is typically normocytic and 
normochromic, with a notable absence of 
reticulocytes, although microcytosis and 
hypochromia may be present in areas with high 
frequencies of α- and β-thalassaemia trait and/or 
iron deficiency14.  
 
Malaria resistance associated with sickle cell 
trait and G6PD deficiency has served as a prime 
example of genetic selection for over a 
century11. Nevertheless, the mechanism of this 
resistance remains a subject of considerable 
debate. While it probably involves innate factors 
such as the reduced ability of Plasmodium 
falciparum parasite to grow and multiply in 
HbAS and G6PD deficient erythrocytes, recent 
findings suggest that it might also involve the 
accelerated acquisition of malaria specific 
immunity12. Reports on the effect of G6PD 
deficiency on patients with sickle cell trait have 
been controversial. Bernstein et al. [15] claimed 
that the combination was beneficial while 
Steinberg et al.16 found no beneficial or adverse 
relation in co–inheritance. In this study we 
investigate the contribution of sickle 
haemoglobin and G6PD deficiency gene in the 
clinico–haematological profile of falciparum 
malaria infected subjects with intent to throw 
more light into the role these genetic defects 
could play in the protection against malaria 
severity. 
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MATERIALS AND METHODS 
 
Study area and subjects  
A total of 75 volunteers aged between 1 to 18 
years, living in the malaria endemic Ndop plain 
of North West province of Cameroon, selected 
after the haemoglobin genotype and G6PD 
deficiency status of 934 individuals were 
determined, participated in the study. The 
volunteers sorting malaria treatment at the Ndop 
District Hospital were divided into four cohort 
groups based on their G6PD deficiency status 
and haemoglobin genotype thus; 30 G6PD non–
deficient HbAS subjects (group A), 30 G6PD 
non–deficient HbAA (group B), 10 G6PD 
deficient HbAA (group C) and 5 G6PD deficient 
HbAS subjects (group D). Selection was based 
on the individual’s accessibility and willingness 
to take part in monitoring for the malaria 
infection for a period of one year. 
 
Blood collection and Tests  
Blood samples (5ml) were collected by 
venipuncture into sample tubes containing 
EDTA as anticoagulant and then rocked gently 
to mix. However, blood samples (0.1ml) for 
routine monthly malaria test were collected by 
thumb pricking using lancets. Subjects were 
monitored for the frequency of malarial 
infection, parasite density, percentage 
parasitaemia, haematological profile, blood 
sugar level, and other clinical malaria symptoms 
such as impaired consciousness, respiratory 
distress, high fever, severe headache, diarrhoea, 
vomiting, weakness and anaemia for a period of 
one year.  
 
Preparation of haemoglobin lysate and 
determination of haemoglobin genotype 
Uncoagulated blood was centrifuged at 3,000 x 
g for ten minutes to separate the red blood cells 
from the plasma. The upper layer was aspirated 
out while the sediment was washed three times 
by re-suspending in equal volumes of normal 
saline (0.85% w/v) and then re-centrifuged at the 
same speed. The packed cells were re-suspended 
in equal volume of normal saline. 20µl of the 
suspended cells was then mixed with 80µl of 
distilled water in a 1:4 dilution to lyse the cells. 
The solution was gently shaken for two minutes 
and then centrifuged at 3,000 x g for 20 minutes. 
The resulting supernatant, Hb lysate, was used 
for the genotype test while the precipitate was 
discarded. The Hb lysate was stored in the 
refrigerator (2-4 oC) until used within four days. 
Alternately, 20µl of uncoagulated whole blood 
was mixed with 60µl of distilled water and the 
resulting Hb lysate spotted directly for Hb 
genotype determination. Haemoglobin 
genotypes were determined by cellulose acetate 
membrane electrophoresis (CAME) of Evans17 
as modified by Uzoegwu18. 
 
Malaria diagnosis 
A total of 934 children (430 males and 604 
females) were tested for malaria parasite based 
on clinical malaria symptoms and confirmed by 
microscopic examination of Giemsa or 
Leishman stained thick and thin blood films. 
The presence of even one parasite per 
microscopic field indicated positivity for malaria 
parasite.  
 
Determinations of parasitaemia and parasite 
density 
Parasitaemia and parasite density were 
determined according to the method of 
Greenwood and Armstrong19 as described in 
Awah & Uzoegwu5. 
 
Determination of G6PD deficiency  
The activity of G6PD was determined by 
fluorescent spot test as described by Beutler et 
al.20. The reaction mixture contained glucose-6-
phosplate (0.01M), NADP+ (0.01M), saponins 
(0.02M), phosphate buffer, pH 7.4 and distilled 
water. Fluorescence was produced due to the 
reduction of NADP+ to NADPH. This reaction is 
coupled with oxidation of glucose-6-phosphate 
to 6-phosphogluconolactone and catalysed by 
G6PD. Specimen with G6PD activity of <20% 
of normal (severe deficiency) do not fluoresce as 
the small amount of NADPH formed is 
reoxidised by glutathione present in the reagent. 
Presence of fluorescence indicated normal cells 
while weak fluorescence indicated slight 
deficiency.  
 
Full blood count 
Haematological indices [erythrocyte counts, 
white blood cell count (WBC), lymphocyte 
counts (LYM), granulocyte counts (GRA), mean 
cell volume (MCV), mean cell haemoglobin 
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(MCH), mean cell haemoglobin 
concentration (MCHC), packed cell volume 
(PCV) or haematocrit (HCT), Hb 
concentration and platelet count (PLT)] 
were analysed using an automated system, 
CELL-DYN 1200 Hematology Analyser 
(Abbott, USA). 
 
Determination of serum fasting blood 
sugar  
Fasting blood sugar (FBS) was assayed with 
a one-touch glucose-monitoring meter (Life 
Scan Inc., USA) as directed in the 





Clinical symptoms during severe malarial 
infection  
Results showed that on a monthly basis a greater 
number of G6PD non-deficient HbAA subjects 
exhibited more frequent and severe clinical 
malarial symptoms when compared with G6PD 
non-deficient sickle heterozygotes, G6PD deficient 
dominant homozygotes (HbAA) and G6PD 
deficient sickle heterozygotes (HbAS). Results 
further showed that G6PD non-deficient HbAS 
subjects and G6PD deficient HbAS subjects had 
significantly fewer (P < 0.05) episodes of severe 
malarial anaemia and higher parasite density (Hb < 
7 g/dl and >10000 parasites/µl) (Table 1). 
 
 
Table 1: Clinical symptoms of falciparum malaria infected HbAA and HbAS subjects 
with and without G6PD deficiency 
 Group A Group B Group C Group D 
Clinical Symptoms G6PD Non-
Deficient 
HbAA (n = 30) 
G6PD Def. 
HbAA  
(n = 10) 
G6PD Non-
Deficient HbAS  
(n = 30) 
G6PD Def. 
HbAS 
 (n = 5)  
 Crude incidence/1000 persons per month 
Severe Malarial Anaemia Episodes 
(Hb < 7g/dl,  >10,000 Parasitaemia) 
1 0.08 - - 
All cause Severe Anaemia Episodes 
(Hb < 7g/dl + any level parasitaemia) 
1.4 0.09 0.32 0.05 
High Density Parasitaemia Episodes 
(>10,000 Parasitaemia) 
1.28 0.15 - - 
Severe fever (Temperature > 40 oC) 0.42 0.27 0.09 0.03 
Severe Headache Episodes 1.44 0.21 1.2 0.08 
Respiratory Distress Episodes  0.12 0.02 - - 
Diarrhoea Episodes 1 0.18 0.96 0.76 
Severe Vomiting Episodes 1.4 0.15 1.24 1 
Cerebral Malaria Episodes 0.2 0.06 - - 
Impaired Consciousness  0.4 0.05 - - 
Hypoglycaemic Episodes 1.28 0.21 0.88 0.02 
Seizure Episodes 0.12 - - - 






Table 2: Haematological profile and parasitaemia of falciparum malaria infected HbAA and 
HbAS individuals with & without G6PD deficiency  
 Group A Group B Group C Group D  
Haematological 












(n = 30) 
G6PD 
Deficient  
HbAS   
(n = 5) 
 
Hb (g/dl) 9.1 ±  1.8 9.6 ±  2.1 11.7 ±  1.04 12.5 ±  1.7 * 
PCV (%) 21.4 ±  4.3 22.5 ±  4.6 26.9 ±  2.5 27.8 ±  0.5 * 
RBC (M/µl) 2.9 ±  0.6 3.2 ±  0.7 3.6 ±  0.4 3.8 ±  0.4 * 
MCV (fl) 73.4 ±  9.4 72.2 ± 8.4 74.5 ±  7.1 73.6 ±  4.2 φ 
MCH (pg) 31.6 ±  4.2 30.9 ±   4.1 32.4 ±  3.2 33 ±  2.2 φ 
MCHC (g/dl) 42.8 ±  3.2 42.8 ±  2.3 43.5 ±  1.6 44.8 ±  2.05 φ 
RDW (%) 15.2 ±  3 14.8 ±  3.3 13.5 ±  2.4 12.8 ±  1.4 * 
Target Cells (%) - - 0.3 ±  0.3 0.5 ±  0.3 φ 
Platelets (K/µl) 289 ± 161 258.7 ±  119.7 270.8 ±  88.8 312.8 ±  159 φ 
WBC (K/µl) 7.5 ±  6.9 7.2 ±  4.6 7.1 ±  4.2 6.3 ±  1.5 φ 
Lymphocytes (K/µl) 3.6±  0.2 3.3 ±  0.1 1.7 ±  0.1 0.9 ±  0.1 * 
Granulocytes (K/µl) 7.1 ±  0.3 3.6 ±  0.2 3.6 ±  0.05 1.7 ±  0.1 φ 
Parasite Density (No/µl) 4349.6 ±  865.4 1291 ±  459.2 1075.3 ±  658.7 478.6 ±  244.6 * 
% Parasitaemia 0.9 ±  0.5 0.6 ±  0.3 0.5 ±  0.3 0.1 ±  0.03 * 
Annual Frequency (times) 3 – 4 2 – 3 1 – 2 ≤ 1 * 
*Significant (P<0.05); φ Not significant (P>0.05) 
 
Haematological profile during falciparum 
Infection 
The data presented on Table 2 show that G6PD 
non-deficient HbAA subjects suffered more 
malaria attack, had significantly (P < 0.05) 
higher parasite densities and higher percentage 
parasitaemia than the G6PD deficient dominant 
homozygotes, G6PD non-deficient sickle 
heterozygotes and G6PD deficient HbAS 
groups. The results also revealed that G6PD 
deficient sickle heterozygotes had significantly 
higher (P < 0.05) Hb concentration, PCV, RBC 
count, RDW, than the G6PD non-deficient 
sickle heterozygotes, G6PD deficient dominant 
homozygotes and G6PD non-deficient HbAA 
subjects. However, G6PD non-deficient HbAA 
subjects had higher WBC and lymphocyte 
counts than G6PD deficient homozygotes, 
though statistically non significant (P > 0.05). 
Also, G6PD deficient sickle heterozygotes 
showed significantly higher (P < 0.01) WBC and 
RDW than those without enzyme deficiency. 
Although each of MCH, MCHC and MCV was 
higher in the sickle heterozygotes with the 
enzyme deficiency, when compared with those 
with the enzyme deficiency, the difference was 




The signs and symptoms of malaria infection in 
humans are caused by the asexual blood stage of 
the parasite2. Severe malaria was observed to be 
complex and could not be accurately represented 
as a single schema. However, several pathogenic 
processes could be combined to lead to severe 
 94 
disease such as rapid expansion of infected RBC 
mass, destruction of both infected and 
uninfected RBCs and microvascular obstruction. 
The spectrum of severity ranged from 
asymptomatic infection in those with acquired 
and innate immunities to rapidly progressive, 
fatal illness. In this study, prodromal symptom 
such as severe headache dominated the malaria 
presentation. Cohort G6PD non-deficient HbAA 
subjects (group A) were observed to be more 
often admitted to hospital for the treatment of 
malaria than G6PD deficient HbAA (group B), 
HbAS non-deficient (group C) and G6PD 
deficient HbAS (group D) subjects. The crude 
incidence of severe malarial anaemia (Hb < 7 
g/dl) and high parasitaemia (> 10,000 
parasites/µl) episodes, cerebral malaria episode, 
hypoglycaemia, impaired consciousness, 
seizure, respiratory distress, severe headache, 
fever, diarrhoea and vomiting were higher in 
group A compared to groups B, C and D 
subjects. The fact that none of the HbAS 
subjects suffered cerebral malaria could suggest 
that HbAS protects against cerebral malaria and 
coma. Since mortality caused by P. falciparum 
infection was related to haemoglobin 
concentration and parasite density21, more HbAS 
and G6PD deficient HbAA subjects had lower 
mortality rate from the malaria compared to 
G6PD non-deficient HbAA individuals. The 
severe anaemia episodes were more predominant 
in children below 5 years old while the cerebral 
malaria episodes although few cases were 
predominant in older children supporting the 
observation of Snow et al.22. The severe anaemia 
observed in this study could neither be drug 
induced since quinine sulfate (200mg) the 
mainly used antimalarial drug has not been 
implicated in haemolysis in G6PD deficiency, 
nor food-induced, since fava beans is not 
consumed in the study area. Severe oxidative 
haemolysis and exercise related rhabdomyolysis 
from co-inheritance of G6PD deficiency and 
HbAS were also not observed in this study area. 
Anaemia became worse after treatment began in 
some group A subjects, probably due to the high 
parasitaemia.  The anaemia was typically 
normocytic and normochromic in some though, 
some expressed a microcytic and hypochromic 
picture implicating other causes for the anaemia 
such as iron deficiency.  
Respiratory distress, defined by deep and 
grasping breathing was common in groups A 
and B subjects compared to groups C and D 
subjects. The subjects of groups A and B were 
severely anaemic implicating therefore the 
massive breakdown of red blood cells during the 
respiratory distress due to poor oxygen transport. 
The subjects as well suffered simple febrile 
seizures and recovered after appropriate 
treatment. Hypoglycaemic episode, most 
common in children with severe malaria23 was 
found to be more common in G6PD non-
deficient HbAA subjects compared to G6PD 
deficient HbAA subjects, G6PD non-deficient 
HbAS and G6PD deficient HbAS. 
Hypoglycaemia was evident at malaria 
presentation and could be due to impaired 
hepatic gluconeogenesis and increased 
consumption of glucose in peripheral tissue as 
well as by parasite. Gluconeogenesis probably 
failed to compensate, in the presence of 
decreased glycogen flux of glucose, increasing 
the risk of hypoglycaemia in falciparum infected 
subjects as reported by Dekker et al.24. 
 
The significantly lower (P < 0.05) Hb 
concentration, PCV, RBC, MCHC and in G6PD 
non-deficient HbAA subjects during the 
progress of malaria when compared with those 
of G6PD deficient HbAA, G6PD non-deficient 
HbAS and G6PD deficient HbAS is indicative of 
less severe malarial anaemia in the later groups. 
The low platelet count in G6PD non-deficient 
HbAA subjects compared to that in G6PD 
deficient heterozygotes is consistent with the 
finding that platelets could form ‘clumps’ with 
Plasmodium-infected erythrocytes, hence  
thrombocytopenia may be helpful as a sensitive 
but not specific marker of active infection25,26 . 
However, low amount of platelets may not only 
be a marker of parasite burden but may be 
protective against severe disease. The higher 
WBC, lymphocyte and granulocyte counts in 
group A subjects compared with those of the 
other groups during the progress of malaria 
could be associated with severe or acute malaria, 
consistent with the report of Molyneux et al.23. 
Group A subjects suffered malaria more 
frequently, had significantly higher parasite 
density and percentage parasitaemia (P < 0.05) 
than groups C and D subjects but not group B. 
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The anaemia herein couldn’t have been due to 
the G6PD deficiency status since subjects 
avoided consumption of oxidant drugs with high 
redox potential. The intraerythrocytic malaria 
parasite is hypothesised to digest haemoglobin 
to supply the amino acids needed for the 
synthesis of their own proteins27. The high 
parasitaemia observed in groups A and B 
subjects therefore, could reflect the high 
consumption of host haemoglobin hence 
anaemia. Excess haemoglobin consumption by 
Plasmodium falciparum is said to represent an 
essential evolutionary strategy to prevent the 
premature haemolysis of the highly 
permeabilised infected red blood cells28. Red 
blood cells with low G6PD activity offered a 
hostile environment to parasite growth and thus 
advantage to G6PD deficient subjects resulting 
in the low parasitaemia observed in group D and 
B subjects. It is observed that sickle 
heterozygotes and G6PD deficient individuals 
experienced reduced fatality and severity of 
malaria disease.  
 
Severe vomiting, diarrhoea and impaired 
consciousness were all characteristics of algid 
malaria involving other organs of the viscera. 
However, it never was as lethal as cerebral 
malaria in which obstruction could block 
glucose flow to the brain and since the brain cell 
depends solely on glucose, death could occur. 
Black water fever in which there is sudden 
appearance of haemoglobin in urine indicating 
severe intravascular haemolysis leading to 
haemoglobinaemia and haemoglobinuria was 
common to groups A, B and C but not to D. 
However, Plasmodium falciparum might not be 
directly involved in the acute lysis as irregular 
use of quinine as chemoprophylaxis could also 
be associated with black water fever. The 
rupturing of about 5-10% of parasitised RBCs in 
malaria might not be sufficient to explain the 
severity of anaemia observed. Severe anaemia 
may also arise from multiple poorly understood 
processes including acute haemolysis of infected 
and uninfected RBC (probably induced by 
autoimmune response), together with loss of iron 
(Fe) through hemozoin and dyserythropoiesis, as 
well as through the interaction of malaria 
infection with other parasitic infections and 
nutritional deficiencies14. 
The clinical features of malaria were diverse in 
severity and syndrome. However, severe 
anaemia, hypoglycaemia and impaired 
consciousness were more common to group A 
subjects than other groups, though the 
mechanism remains elusive. Since G6PD is a 
membrane bound enzyme, HbS/membrane 
interaction might act as primum movens for the 
diverse cellular mechanisms which reduce 
falciparum invasion, impair the parasite survival 
and development within the red blood cells and 
accelerate infected erythrocyte clearance by 
phagocytosis. Consequently, the severity and 
clinical symptoms of falciparum malaria are 
ameliorated. However, these two genetic defects 
are likely playing different roles in clinical   P. 
falciparum malaria. Sickle haemoglobin seems 
to be a more powerful malarial resistant factor 
than G6PD deficiency. It could therefore be 
concluded that inheritance of sickle and G6PD 
deficiency genes is beneficial since inheriting 
them protects against severe malaria. G6PD 
deficiency and HbS in HbAS may be acting as 
natural vaccines against severe Plasmodium 
falciparum malaria. 
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